SCHEMBL3342489

SCHEMBL3342489

Cc1ccc(Cl)cc1N1CCNCC1.c1ccc(N2CCNCC2)nc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLD1 Q13393 1/20 0.62
ADRB1 P08588 1/20 0.49
ADRB2 P07550 1/20 0.48
NCF1 P14598 1/20 0.48
HSD17B10 Q99714 4/20 0.48
ALDH1A1 P00352 4/20 0.48
CYP2C9 P11712 3/20 0.48
CYP2C19 P33261 3/20 0.48
HPGD P15428 2/20 0.48
HTR3E A5X5Y0 2/20 0.48
HTR3B O95264 2/20 0.48
HTR3A P46098 2/20 0.48
HTR3D Q70Z44 2/20 0.48
HTR3C Q8WXA8 2/20 0.48
USP2 O75604 2/20 0.48
CYP3A4 P08684 2/20 0.48
CYP2D6 P10635 2/20 0.48
TSHR P16473 2/20 0.48
MEN1 O00255 1/20 0.48
MAPK1 P28482 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30080727 0.84 HTR3A (0.64) ADRB1ADRB2NCF1ALDH1A1CYP2C9
SCHEMBL255186 0.84 HTR3A (0.64) ADRB1ADRB2NCF1ALDH1A1CYP2C9
Hydrochloric Acid SCHEMBL19385628 0.82 HTR3A (0.62) ADRB1ADRB2NCF1ALDH1A1CYP2C9
SCHEMBL893565 0.79 PLD1 (1.00) PLD1ADRB1HSD17B10ALDH1A1CYP2C9
SCHEMBL7900 0.79 PLD1 (1.00) PLD1ADRB1HSD17B10ALDH1A1CYP2C9
SCHEMBL29400889 0.79 PLD1 (1.00) PLD1ADRB1HSD17B10ALDH1A1CYP2C9
Hydrochloric Acid SCHEMBL4165242 0.78 PLD1 (0.96) PLD1HSD17B10ALDH1A1CYP2C9CYP2C19
Ammonia Solution, Strong SCHEMBL17926100 0.78 PLD1 (0.96) PLD1ADRB1HSD17B10ALDH1A1CYP2C9
Hydrochloric Acid SCHEMBL27481639 0.78 PLD1 (0.96) PLD1HSD17B10ALDH1A1CYP2C9CYP2C19
Piperazine SCHEMBL27920772 0.78 PLD1 (0.96) PLD1ADRB1HSD17B10ALDH1A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100063047-A1 AMINOPYRIMIDINE INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE KALYPSYS, INC. (US) 2010-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063047-A1 AMINOPYRIMIDINE INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE HRH4, HRH2, HRH3 PLD1 3485/4885ADRB1 993/4885ADRB2 882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.